Catalyst Wire Dossier Catalyst Wire Dossier

adapalene 0.3% - benzoyl peroxide 2.5%

adapalene; benzoyl peroxide · Galderma R&D
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for adapalene 0.3% - benzoyl peroxide 2.5%, covering 2019-11-15 to 2019-11-15. Get the full timeline:

Most recent: Clinical Trial Update: Subject Reported Outcomes With Use of Adapalene 0.3% - Benzoyl Peroxide (BPO) 2.5% in Dark Skin Acne [Phase 3]

See pricing